Valora Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Valora Therapeutics Inc. - overview
Established
2022
Location
La Jolla, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2023 by Carolyn Bertozzi, Valora Therapeutics Inc. , a. k. a.
Valora Therapeutics is a biotechnology company that specializes in immunotherapy development. In November 2024, Valora Therapeutics Inc. raised USD 30 million in seed funding co-led by Avalon Bio Ventures, Bregua Corporation, and TigerGene LLC, with participation from Alexandria Venture Investments and Correlation Ventures. As of November 2023, Miguel Garcia-Guzman is the CEO of the company.
Valora Therapeutics specializes in immunotherapy solutions through its proprietary AbLec™ platform, which focuses on decoding the complex sugar code involved in cellular and immune interactions. The platform addresses deficiencies in immune communication prevalent in various diseases, offering a novel approach to treatment. By leveraging advancements in glycobiology, Valora Therapeutics aims to develop therapies that can significantly improve patient outcomes across a broad range of conditions, specifically for patients suffering from immune-related diseases, including cancer and autoimmune disorders. Valora Therapeutics plans to utilize its proceeds from November 2024 funding to further explore and develop the full potential of the AbLec platform, advancing lead molecules into preclinical development and validating specific mechanisms of action.
Current Investors
Alexandria Venture Investments, Correlation Ventures, Bregua Corporation
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals
Website
www.valoratherapeutics.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.